Why the InvoCare Limited share price has surged higher

The InvoCare Limited (ASX:IVC) share price has leapt higher in morning trade following a strong full-year result. Is it a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The InvoCare Limited (ASX: IVC) share price has jumped 5% to $13.70 this morning after the funeral, cemetery, and cremation operator announced a solid preliminary full-year result.

Key takeaways include:

  • Total sales revenue increased 3.3% to $450.7 million year-on-year.
  • EBITDA of $112.3 million, an increase of 6.5%.
  • Net gain on undelivered prepaid contracts after tax of $16 million.
  • Net profit after tax up 29.4% to $70.9 million.
  • Earnings per share of 67.9 cents.
  • Final fully franked dividend of 25.5 cents per share, bringing its full-year dividend to 42.5 cents per share.
  • Funds under management increased 12% to $473.1 million.

Driving the top line growth was the solid performance of its Australian and Singapore segments. Revenue in these segments rose 3.5% and 4.3% respectively, offsetting a 3.1% decline in its New Zealand segment.

Although the company posted a stunning 29.4% rise in net profit, I feel it is important to point out that the majority of this growth came from a $16 million net gain on undelivered prepaid contracts after tax.

Taking this gain out of the equation for both FY 2015 and FY 2016's results would mean net profit after tax growth of 11.9%. Although this growth is slower than the headline result, I still believe it's a strong performance nonetheless.

The company has however lost around 77 basis points of market share during the year according to management.

Increased competitor activity and lower pricing in Queensland, Western Australia, and northern New South Wales hit the company. Whilst it was a similar story in New Zealand and Singapore as well, pleasingly the company made modest market share gains in Victoria and South Australia.

Management does have plans to address the market share decline. It believes improvements in product offering and branding, further acquisitions, new locations, and a renewed focus on local leadership provides significant opportunities to grow market share.

Is it a buy?

Whilst its shares may be priced at 20x earnings, I believe this is a fair multiple for InvoCare considering its defensive qualities and market-leading position.

I believe management's plan to address market share declines will not only stop the rot, but will also expand its market-leading position even further. I expect this to allow the company to grow earnings in the high single digits for the foreseeable future.

At this point in time I would recommend an investment in InvoCare ahead of consumer discretionary peers such as Navitas Limited (ASX: NVT) and Idp Education Ltd (ASX: IEL).

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »